NHL, Relapsed clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
open to eligible people ages 3-75
This study is a multi-center study to evaluate the safety of KUR-502 in subjects with refractory/relapsed B-cell NHL or leukemia (ALL or CLL).